Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide

Diabetes Care

Volumn 31, Issue 5, 2008, Pages 945-951

  Hwang, Janice J ^a   Chan, Jean L ^a   Ntali, Georgia ^b   Malkova, Dalia ^c   Mantzoros, Christos S ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HAROKOPIO UNIVERSITY   (Greece)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d Division of Endocrinology Diabetes and Hypertension   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; GLUCOSE; INSULIN; LEPTIN; PANCREAS HORMONE; PANCREAS POLYPEPTIDE; PLACEBO; RECOMBINANT METHIONYL HUMAN LEPTIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; AMYLOID;

AMENORRHEA; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; DOSE RESPONSE; ENERGY CONSUMPTION; FEMALE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOLEPTINEMIA; HYPOTHALAMUS; MALE; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; ADULT; BLOOD; GENETICS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; METABOLISM; MIDDLE AGED; PANCREAS; PATHOPHYSIOLOGY; PATIENT SELECTION; REFERENCE VALUE; SECRETION;

ADULT; AMENORRHEA; AMYLOID; BLOOD GLUCOSE; ENERGY INTAKE; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; LEPTIN; MALE; MIDDLE AGED; PANCREAS; PANCREATIC POLYPEPTIDE; PATIENT SELECTION; RECOMBINANT PROTEINS; REFERENCE VALUES;

EID: 48649084313     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2433     Document Type: Article

References (41)

1. Young A, Denaro M: Roles of amylin in diabetes and in regulation of nutrient load. Nutrition 14:524-527, 1998
2. Adrian TE, Bloom SR, Bryant MG, Polak JM, Heitz PH, Barnes AJ: Distribution and release of human pancreatic polypeptide. Gut 17:940-944, 1976
3. Weyer C, Maggs DG, Young AA, Kolter- man OG: Amylin replacement with pram- lintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control. Curr Pharm Des 7:1353-1373, 2001
4. Huda MS, Wilding JP, Pinkney JH: Gut peptides and the regulation of appetite. Obes Rev 7:163-182, 2006
5. Lutz TA, Mollet A, Rushing PA, Riediger T, Scharrer E: The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats. Int J Obes Relat Metab Disord 25:1005-1011, 2001
6. Rushing PA, Hagan MM, Seeley RJ, Lutz TA, D'Alessio DA, Air EL, Woods SC: Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 142:5035, 2001
7. Hollander P, Maggs DG, Ruggles JA, Fine- man M, Shen L, Kolterman OG, Weyer C: Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients. Obes Res 12:661-668, 2004
8. Aronne L, Fujioka K, Aroda V, Chen K, Halseth A, Kesty NC, Burns C, Lush CW, Weyer C: Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study. J Clin Endocrinol Metab 92:2977-2983, 2007
9. Ueno N, Inui A, Iwamoto M, Kaga T, Asakawa A, Okita M, Fujimiya M, Naka- jima Y, Ohmoto Y, Ohnaka M, Nakaya Y, Miyazaki JI, Kasuga M: Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology 117:1427-1432, 1999
10. Malaisse-Lagae F, Carpentier JL, Patel YC, Malaisse WJ, Orci L: Pancreatic polypep- tide: a possible role in the regulation of food intake in the mouse: hypothesis. Ex- perientia 33:915-917, 1977
11. Pieramico O, Malfertheiner P, Nelson DK, Glasbrenner B, Ditschuneit H: Interdiges- tive cycling and post-prandial release of pancreatic polypeptide in severe obesity. IntJObes 14:1005-1011, 1990
12. Wisen O, Bjorvell H, Cantor P, Johansson C, Theodorsson E: Plasma concentrations of regulatory peptides in obesity following modified sham feeding (MSF) and a liquid test meal. Regul Pept 39:43-54, 1992
13. Lassmann V, Vague P, Vialettes B, Simon MC: Low plasma levels of pancreatic polypeptide in obesity. Diabetes 29:428430, 1980
14. Marco J, Zulueta MA, Correas I, Villan- ueva ML: Reduced pancreatic polypeptide secretion in obese subjects. J Clin Endocrinol Metab 50:744-747, 1980
15. Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M, Frost GS, Ghatei MA, Bloom SR: Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 88:3989-3992, 2003
16. Seufert J, Kieffer TJ, Leech CA, Holz GG, Moritz W, Ricordi C, Habener JF: Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adi- pogenic diabetes mellitus. JClin Endocri- nolMetab 84:670-676, 1999
17. Karlsson E, Stridsberg M, Sandler S: Leptin regulation of islet amyloid polypeptide secretion from mouse pancreatic islets. Biochem Pharmacol 56:1339-1346, 1998
18. Osto M, Wielinga PY, Alder B, Walser N, Lutz TA: Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin. Physiol Behav 91:566-572, 2007
19. RothJD, Hughes H, Kendall E, Baron AD, Anderson CM: Antiobesity effects of the β-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. Endocrinology 147: 5855-5864, 2006
20. Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M, Fujino MA, Nii- jima A, Meguid MM, Kasuga M: Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 124:1325-1336, 2003
21. Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS: The role of falling lep- tin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 111:1409 - 1421, 2003
22. Chan JL, Matarese G, Shetty GK, Raciti P, Kelesidis I, Aufiero D, De Rosa V, Perna F, Fontana S, Mantzoros CS: Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. Proc Natl Acad Sci USA 103:84818486, 2006
23. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, Karalis A, Mantzo- ros CS: Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 351:987-997, 2004
24. Blackard WG, CloreJN, KellumJM: Amy- lin/insulin secretory ratios in morbidly obese man: inverse relationship with glucose disappearance rate. JClin Endocrinol Metab 78:1257-1260, 1994
25. Enoki S, Mitsukawa T, Takemura J, Na- kazato M, Aburaya J, Toshimori H, Mat- sukara S: Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 15:97-102, 1992
26. Ludvik B, Lell B, Hartter E, Schnack C, Prager R: Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes. Diabetes 40: 1615-1619, 1991
27. Kahn SE, Verchere CB, Andrikopoulos S, Asberry PJ, Leonetti DL, Wahl PW, Boyko EJ, Schwartz RS, Newell-Morris L, Fuji- moto WY: Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans. Diabetes 47:640-645, 1998
28. Makimattila S, Fineman MS, Yki-Jarvinen H: Deficiency of total and nonglycosy- lated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes. J Clin Endocrinol Metab 85:2822-2827, 2000
29. Nyholm B, Fineman MS, Koda JE, Schmitz O: Plasma amylin immunoreac- tivity and insulin resistance in insulin resistant relatives of patients with non- insulin-dependent diabetes mellitus. Horm Metab Res 30:206-212, 1998
30. Gulli G, Rossetti L, DeFronzo RA: Hyper- amylinemia is associated with hyper- insulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican- American non-insulin-dependent diabetic parents. Metabolism 46:1157-1161, 1997
31. Knowles NG, Landchild MA, Fujimoto WY, Kahn SE: Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes. Di abetes Care 25:292-297, 2002
32. Ratner RE, Dickey R, Fineman M, Maggs DG, Shen L, Strobel SA, Weyer C, Kolter- man OG: Amylin replacement with pram- lintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in type 1 diabetes mellitus: a 1-year, randomized controlled trial. Diabet Med 21:1204-1212, 2004
33. Lutz TA, Althaus J, Rossi R, Scharrer E: Anorectic effect of amylin is not transmit ted by capsaicin-sensitive nerve fibers. Am J Physiol 274:R1777-R1782, 1998
34. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB, lmquist JK: Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23:775-786, 1999
35. Roth J, Weyer C, Anderson C, Parkes D, Baron A: Leptin responsitivity restored in leptin-resistant diet-induced obese (DIO) rats: synergistic actions of amylin and lep- tin for reduction of body eight and fat (Abstract). In Proceedings of the 66th Scientific Sessions of the American Diabetes Association. Alexandria, VA, American Diabetes Association, 2006
36. Grabler V, Lutz TA: Chronic infusion of the amylin antagonist AC 187 increases feeding in Zucker fa/fa rats but not in lean controls. Physiol Behav 81:481-488, 2004
37. ZipfWB, O'Dorisio TM, Cataland S, Sotos J: Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome. J Clin Endocrinol Metab 52:1264-1266, 1981
38. Berntson GG, Zipf WB, O'Dorisio TM, Hoffman JA, Chance RE: Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides 14: 497-503, 1993
39. Koska J, DelParigi A, De Court, Weyer C, Tataranni PA: Pancreatic polypeptide is involved in the regulation of body weight in Pima Indian male subjects. Diabetes 53: 3091-3096, 2004
40. ChanJL, BullenJ, LeeJH, Yiannakouris N, Mantzoros CS: Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab 89:335 343, 2004
41. Chan JL, Stoyneva V, Kelesidis T, Raciti P, Mantzoros CS: Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated bylep- tin. Diabetologia 49:169-173, 2006